|
ACACA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.63320000000123E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.956900E-04 |
| Normal-vs-Stage2 |
6.519800E-02 |
| Normal-vs-Stage3 |
1.095360E-01 |
| Normal-vs-Stage4 |
1.040990E-01 |
| Stage1-vs-Stage2 |
9.983200E-01 |
| Stage1-vs-Stage3 |
3.803600E-01 |
| Stage1-vs-Stage4 |
4.829800E-01 |
| Stage2-vs-Stage3 |
5.315400E-01 |
| Stage2-vs-Stage4 |
4.654400E-01 |
| Stage3-vs-Stage4 |
3.119000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.045610E-04 |
| Normal-vs-AfricanAmerican |
2.842000E-02 |
| Normal-vs-Asian |
5.958800E-03 |
| Caucasian-vs-AfricanAmerican |
1.918640E-01 |
| Caucasian-vs-Asian |
3.852200E-01 |
| AfricanAmerican-vs-Asian |
1.690770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.369600E-04 |
| Normal-vs-Female |
1.000520E-04 |
| Male-vs-Female |
6.272300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.787600E-02 |
| Normal-vs-Extreme_Weight |
5.603000E-03 |
| Normal-vs-Obese |
1.098820E-03 |
| Normal-vs-Extreme_Obese |
2.687000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.589600E-01 |
| Normal_Weight-vs-Obese |
2.784600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.484400E-01 |
| Extreme_Weight-vs-Obese |
5.459200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.017600E-01 |
| Obese-vs-Extreme_Obese |
6.570200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.295700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.73309999999383E-05 |
| Normal-vs-Age(61-80Yrs) |
3.700900E-03 |
| Normal-vs-Age(81-100Yrs) |
8.060400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.342400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.781500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.897500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.256300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.374900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.126100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.973700E-04 |
| Normal-VS-Type2 PRCC |
7.921800E-02 |
| Normal-VS-KIRP CIMP |
1.758470E-02 |
| Normal-VS-Unclassified PRCC |
7.369700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.186390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.038600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.483000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.281000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.962200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.607600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.722800E-01 |
| Normal-vs-N1 |
5.476300E-02 |
| Normal-vs-N2 |
2.575200E-03 |
| N0-vs-N1 |
1.424820E-01 |
| N0-vs-N2 |
4.156600E-03 |
| N1-vs-N2 |
2.246000E-01 |
|
|
